Jump to content

Asymbescaline

From Wikipedia, the free encyclopedia
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
Asymbescaline
Names
Preferred IUPAC name
2-(3,4-Diethoxy-5-methoxyphenyl)ethan-1-amine
Other names
3,4-Diethoxy-5-methoxyphenethylamine
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
UNII
  • InChI=1S/C13H21NO3/c1-4-16-12-9-10(6-7-14)8-11(15-3)13(12)17-5-2/h8-9H,4-7,14H2,1-3H3 checkY
    Key: VFOAVFQWZYUFQZ-UHFFFAOYSA-N checkY
  • InChI=1/C13H21NO3/c1-4-16-12-9-10(6-7-14)8-11(15-3)13(12)17-5-2/h8-9H,4-7,14H2,1-3H3
    Key: VFOAVFQWZYUFQZ-UHFFFAOYAI
  • O(c1c(OC)cc(cc1OCC)CCN)CC
Properties
C13H21NO3
Molar mass 239.315 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
checkY verify (what is checkY☒N ?)

Asymbescaline (3,4-diethoxy-5-methoxyphenethylamine) is a lesser-known psychedelic drug. It is a homolog of mescaline. Asymbescaline was first synthesized by Alexander Shulgin. In his book PiHKAL, the dosage range is listed as 200–280 mg, and the duration listed as 10–15 hours.[1] Asymbescaline produces few to no effects.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of asymbescaline.

See also

References